PD59-03 HYPOXIA INDUCE NEUROENDOCRINE DIFFERENTIATION OF PROSTATE CANCER VIA ANDROGEN RECEPTOR RELATED SIGNALS

Yun Cui,Yin Sun,Yang,Shuai Hu,Yinong Niu,Xiaodong Zhang,Shuyuan Yeh,Chawnshang Chang,Jie Jin
DOI: https://doi.org/10.1097/ju.0000000000000969.03
IF: 7.6
2020-01-01
The Journal of Urology
Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology III (PD59)1 Apr 2020PD59-03 HYPOXIA INDUCE NEUROENDOCRINE DIFFERENTIATION OF PROSTATE CANCER VIA ANDROGEN RECEPTOR RELATED SIGNALS Yun Cui*, Yin Sun, Yang Yang, Shuai Hu, Yinong Niu, Xiaodong Zhang, Shuyuan Yeh, Chawnshang Chang, and Jie Jin Yun Cui*Yun Cui* More articles by this author , Yin SunYin Sun More articles by this author , Yang YangYang Yang More articles by this author , Shuai HuShuai Hu More articles by this author , Yinong NiuYinong Niu More articles by this author , Xiaodong ZhangXiaodong Zhang More articles by this author , Shuyuan YehShuyuan Yeh More articles by this author , Chawnshang ChangChawnshang Chang More articles by this author , and Jie JinJie Jin More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000969.03AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Development of the neuroendocrine differentiation (NED) in prostate cancer (PCa) has been linked to the failure of androgen deprivation therapy. And it was also regarded as the main origin of neuroendocrine PCa, which is a terminal lethal cancer with little effective therapies. This study aimed to study the role of hypoxia, especially hypoxia induced androgen receptor (AR) signals, in the NED of PCa and explore the potential way to restrain NED development. METHODS: Hypoxia was achieved by maintaining the cells at 1% O2, 5% CO2 and 94% N2 in a hypoxic chamber with oxygen sensor controls. Immunohistochemistry, immunoprecipitation assay, chromatin immunoprecipitation assay, CRISPR-CAS9 mediated gene transactivation, orthotropic xenograft, cell culture, quantitative RT-PCR, immunoblotting, bioinformatics analysis, lentivirus packaging and luciferase reporter assay were used to study hypoxia induced NED of PCa in vivo and in vitro. RESULTS: PCa performed NED under hypoxia condition with morphology change and neuroendocrine-related marker increasing. In vitro studies indicated that hypoxia induce NED via suppressing the AR signals. And mechanism dissection demonstrated hypoxia could suppress AR protein via AKT/MDM2 mediated ubiquitination of the AR protein. AR could regulate miRNA-449c-5p which suppress ASCL1 expression at the transcriptional level. Importantly, human clinical data survey also revealed a positive correlation between hypoxia and NED. In vivo orthotropic xenograft indicated miR-449c-5p could suppress NED development in PCa. CONCLUSIONS: Results from human clinical data survey and preclinical studies conclude that hypoxia may increase NED via altering the AKT/MDM2/AR/miRNA-449c-5p/ASCL1 signals in PCa, and targeting these newly identified AR-mediated signals with miRNA-449c-5p may help us to better suppress PCa progression via reducing the development of NED. Source of Funding: Beijing Natural Science Foundation (No. 7184214) © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e1205-e1206 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Yun Cui* More articles by this author Yin Sun More articles by this author Yang Yang More articles by this author Shuai Hu More articles by this author Yinong Niu More articles by this author Xiaodong Zhang More articles by this author Shuyuan Yeh More articles by this author Chawnshang Chang More articles by this author Jie Jin More articles by this author Expand All Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?